ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-OR08

Differential Roles of Regnase3 in Resident Macrophages vs. Renal Tubular Epithelial Cells in Kidney Injury

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms


  • Li, Chenyu, Klinikum der Universitat Munchen Medizinische Klinik und Poliklinik IV - Standort Ziemssenstrasse, Munchen, Bayern, Germany
  • Anders, Hans J., Klinikum der Universitat Munchen Medizinische Klinik und Poliklinik IV - Standort Ziemssenstrasse, Munchen, Bayern, Germany

RNA-binding proteins are a class of proteins that regulate RNA and have been implicated in a wide range of diseases. Regnase3 as one of those proteins has been shown to promote inflammation by increasing TNF in macrophages (Mφ). However, the full extent of its functions in kidney disease remains unknown. We hypothesized that Regnase3 plays a role in both kidney resident Mφ and renal tubular epithelial cells (RTEC), influencing inflammation and kidney repair after injury.


A series of genetically-modified mice were developed, including the Pax8rTtA, TetOCre, receptor activator of nuclear factor kappa-Β (Rank, a lineage tracer for kidney resident Mφ)-Cre (RankCre), and Regnase3 floxed (Regnase3fl/fl) mice. Upon these mice, we applied a range of kidney injury models involving unilateral ischemia-reperfusion and nephrocalcinosis. Furthermore, scRNA-seq and RNA-seq were utilized to investigate the underlying mechanisms.


The scRNA-seq showed both Regnase3 is highly expressed in the kidney Mφ and positively correlated with the chemokines, Mφ phagocytosis, and Mφ maturation after kidney injury. In vivo, after the kidney injury, the RankCre-Regnase3fl/fl (Regnase3 conditional KO in kidney resident Mφ) mice suffered from more inflammation, characterized by CCR2 positive pro-inflammatory Mφ accumulation. In vitro, Regnase3 is involved in modulating resident Mφ polarization towards the pro-inflammatory and migration, indicating that it contributes to Mφ-related inflammation.

Next, we aimed to examine the role of Regnase3 in RTEC. Through in silico, we found that Regnase3 is highly expressed in healthy RTEC but reduced following injury, and it controls early apoptosis. In vivo and in vitro experiments suggested that the Regnase3 deletion in RTEC (Pax8rTtA-TetOCre-Regnase3fl/fl) against kidney injury and promote the repair of RTEC. Regnase3 targets pre-RNA and modulates alternative splicing by increasing skipped exon events and decreasing the probability of retained intron events.


Regnase3 contributes to kidney injury but the impact of it is contingent upon the specific cell lineage in question. The RankCre-Regnase3fl/fl leads to an exacerbation of kidney injury by increasing pro-inflammatory Mφ recruitment, whereas the Pax8rTtA-TetOCre-Regnase3fl/fl leads to an improvement after injury through its effects on cell death and RTEC repair.